Bladder Cancer Trial, Recruiting (NCT06548529)

Bladder Cancer Trial, Recruiting NCT06548529 Sponsor: Peking University Cancer Hospital & Institute Condition: Bladder Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06548529 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Bladder Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older and are generally able to carry out daily activities with little or no limitation
Your cancer cannot be removed by surgery, or it has spread to other parts of the body
Your tumor has tested positive, or possibly positive, for a protein called HER2
You have previously been treated with specific cancer medicines (trastuzumab and taxane) for advanced cancer, or your cancer came back within 6 months of receiving these medicines before or after surgery
Your heart, kidneys, liver, bone marrow, and blood clotting are all working well enough
You are currently receiving a type of cancer treatment called an anti-HER2 ADC (a targeted drug that delivers treatment directly to HER2-positive cancer cells)
Your doctor expects you to live for more than 3 months

Who may not be able to join:

You have serious problems with how your liver or kidneys are working
You are pregnant or planning to become pregnant
You are unable to stay still or hold a position for about 30 minutes (confirm with trial site)
You do not wish to take part in the clinical trial
You experience severe anxiety in enclosed spaces (claustrophobia) or have other mental health conditions that may affect participation
The trial team believes, for any other reason, that joining the trial would not be appropriate for you

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06548529

Sponsor: Peking University Cancer Hospital & Institute

Phase: Not Applicable

Status: Recruiting

Condition: Bladder Cancer

More information: https://clinicaltrials.gov/study/NCT06548529

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older and are generally able to carry out daily activities with little or no limitation
Your cancer cannot be removed by surgery, or it has spread to other parts of the body
Your tumor has tested positive, or possibly positive, for a protein called HER2
You have previously been treated with specific cancer medicines (trastuzumab and taxane) for advanced cancer, or your cancer came back within 6 months of receiving these medicines before or after surgery
Your heart, kidneys, liver, bone marrow, and blood clotting are all working well enough
You are currently receiving a type of cancer treatment called an anti-HER2 ADC (a targeted drug that delivers treatment directly to HER2-positive cancer cells)
Your doctor expects you to live for more than 3 months

Who may not be able to join:

You have serious problems with how your liver or kidneys are working
You are pregnant or planning to become pregnant
You are unable to stay still or hold a position for about 30 minutes (confirm with trial site)
You do not wish to take part in the clinical trial
You experience severe anxiety in enclosed spaces (claustrophobia) or have other mental health conditions that may affect participation
The trial team believes, for any other reason, that joining the trial would not be appropriate for you

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Peking University Cancer Hospital & Institute

Registry

ClinicalTrials.gov

Start date

1 June 2024

Est. completion

1 December 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

SUV

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov